Cerus Corp (CERS)-Medical Equipment-Deals and Alliances Profile

Cerus Corp (CERS)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME26394D
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria and parasites present in donated blood. The product is for use with three blood components, platelets, plasma and red blood cells. Cerus is marketed and sold in several countries worldwide including the US, Belgium, Kuwait, France, Spain, Portugal, Switzerland, CIS countries and other countries. Cerus is headquartered in Concord, California, the US.

Cerus Corp (CERS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cerus Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cerus Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Cerus Corp, Medical Equipment, Deal Details 11

Partnerships 11

Cerus Enters into Agreement with Haemonetics 11

Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 11

Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 12

Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 13

Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 14

Cerus Enters Into Distribution Agreement With Ilex Biotech 15

Equity Offering 15

Cerus Plans to Raise USD70 Million in Public Offering of Shares 15

Cerus Prices Public Offering of Shares for USD70 Million 16

Cerus Completes Public Offering Of Shares For US$40.3 Million 17

Cerus Corp-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

May 03, 2017: Cerus Reports First Quarter 2017 Results 23

Mar 07, 2017: Cerus Reports Fourth Quarter and Year End 2016 Results 24

Nov 03, 2016: Cerus Reports Third Quarter 2016 Results 26

Aug 04, 2016: Cerus Reports Second Quarter 2016 Results 28

May 03, 2016: Cerus Corporation Reports First Quarter 2016 Results 30

Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results 32

Corporate Communications 34

Aug 09, 2016: Vivek Jayaraman Appointed as Cerus Corporation's Chief Commercial Officer 34

Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region 35

Product News 36

Mar 16, 2016: Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma 36

Mar 15, 2016: Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA's Revised Guidance Document on Bacterial Safety Standards for Platelets 37

Mar 09, 2016: Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology 38

Feb 09, 2016: Cerus Enters Multi-Year Agreement with the American Red Cross for the Use of INTERCEPT Platelets and Plasma 39

Jan 14, 2016: AABB Authorizes Use of the INTERCEPT Blood System for Platelets to Reduce the Risk of Transfusion-Associated Graft Versus Host Disease 40

Jan 05, 2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma 41

Product Approvals 42

Mar 16, 2016: Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma 42

Other Significant Developments 43

Jun 07, 2017: Cerus Provides Update on U.S. Platelet Additive Solution Supply 43

Oct 10, 2016: Cerus Announces that Hemolife Fundacion Banco Nacional de Sangre Has Entered into Routine Use of the INTERCEPT Blood System 44

Jul 11, 2016: Cerus Provides an Update on Adoption by Blood Centers of America Members for the INTERCEPT Blood System for Platelets and Plasma 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

Cerus Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Cerus Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cerus Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cerus Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Cerus Corp, Medical Equipment, Key Facts, 2016 1

Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cerus Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cerus Corp, Deals By Market, 2011 to YTD 2017 9

Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Cerus Enters into Agreement with Haemonetics 11

Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 11

Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 12

Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 13

Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 14

Cerus Enters Into Distribution Agreement With Ilex Biotech 15

Cerus Plans to Raise USD70 Million in Public Offering of Shares 15

Cerus Prices Public Offering of Shares for USD70 Million 16

Cerus Completes Public Offering Of Shares For US$40.3 Million 17

Cerus Corp, Key Competitors 20

Cerus Corp, Key Employees 21

Cerus Corp, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cerus Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com